• No results found

Molecular Biotechnology Programme Uppsala University School of Engineering

N/A
N/A
Protected

Academic year: 2022

Share "Molecular Biotechnology Programme Uppsala University School of Engineering"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Molecular Biotechnology Programme

Uppsala University School of Engineering

UPTEC X 08 019 Date of issue 2008-04

Author

Mats Ljung

Title (English)

Operation and evaluation of a pilot wastewater plant at GE Healthcare in Uppsala

Title (Swedish) Abstract

A lab scale pilot plant for biological wastewater treatment has been built at GE Healthcare in Uppsala. The aim was to imitate the moving bed biofilm reactors of the on-site wastewater treatment plant, creating the same environmental conditions for biological activity in the bioreactors of the pilot. Once accomplished the likeness to the main plant was evaluated using total organic carbon (TOC) reduction measurements and terminal-restriction fragment length polymorphism (T-RFLP) analyses of the biofilm communities. A correlation between the systems is obvious but unfortunately the difference is significant.

Keywords

biological wastewater treatment, biofilm, MBBR, suspended carrier, TOC, T-RFLP Supervisors

Anders Selmer

Section Manager, GE Healthcare

Scientific reviewer

Sara Hallin

Associate Professor, Swedish University of Agricultural Sciences

Project name Sponsors

Language

English

Security

ISSN 1401-2138 Classification

Supplementary bibliographical information Pages

38

Biology Education Centre Biomedical Center Husargatan 3 Uppsala Box 592 S-75124 Uppsala Tel +46 (0)18 4710000 Fax +46 (0)18 555217

References

Related documents

It showed large dynamic range, no measureable non-specific binding and high sensitivity (with linear range around 0.1 – 10 µg/ml depending on the proteins). The method

Escherichia coli, 23S rRNA, Post-transcriptional modification, In vitro, Peptidyl transferase centre, domain V, Methylation, Pseudouridine, Reverse

The fibrinolytic enzyme tissue type plasminogen activator (t-PA) is released by the vascular endothelium to limit the growth of blood clots and ultimately prevent the occurrence of

investigate the presence of P4 in the brain, in neuromuscular junctions and in adrenal glands, the colocation between P4 and VAChT respectively P4 and VMAT and the possibility that P4

The information obtained by using these algorithms could contribute to the development of new drugs by generating new ligands that target specific high-energy , unfavorable

Results from the project shows that when multiplexing there are differences in measured IgE- levels between an existing singleplex method and the multiplex prototype. The project also

A method for measuring cell concentration and identity based on flow cytometry (FCM) and fluorescent marking is developed and subsequently compared with traditional plating based

Here we have attempted to produce the serine proteases rat mast cell protease 2 and mouse mast cell protease 5 in a culture of HEK 293 cells; and mouse mast cell protease 4,